MEDINET Japan and Stempeutics India sign option licence agreement for Stempeucel in Japan EP News Bureau Oct 27, 2025 The agreement grants MEDINET rights to develop and commercialise Stempeucel for CLTI indication in Japan, with manufacturing to…
Alkem, in partnership with Stempeutics, launches stem cell therapy to treat knee osteoarthritis EP News Bureau Sep 20, 2022 The treatment comprises a single intra-articular injection of “StemOne” in an outpatient procedure with no anaesthesia requirement
DCGI gives limited approval to market Stempeutics’ allogeneic cell therapy Usha Sharma May 30, 2016 Stempeucel is used in the treatment of Buerger’s disease
